In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects
Condition: Fibrodysplasia Ossificans ProgressivaIntervention: Drug: PalovaroteneSponsor: Clementia Pharmaceuticals Inc.Not yet recruiting - verified August 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Fibrodysplasia Ossificans Progressiva | Research